A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer
Phase 2 Terminated
9 enrolled 11 charts
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
61 enrolled 29 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Phase 1/2 Terminated
31 enrolled 19 charts
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
Phase 1/2 Terminated
47 enrolled 11 charts
TRACE
Terminated
246 enrolled 18 charts
Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
Phase 2 Terminated
14 enrolled 6 charts
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
Phase 4 Terminated
21 enrolled 12 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
Phase 3 Terminated
623 enrolled 14 charts
UW17104
Phase 2 Terminated
5 enrolled 9 charts
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
Phase 1/2 Terminated
3 enrolled 10 charts
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Phase 2 Terminated
7 enrolled 5 charts
PrE0801
Phase 2 Terminated
3 enrolled 7 charts
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Phase 2 Terminated
73 enrolled 17 charts
Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
Phase 2 Terminated
10 enrolled 8 charts
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Phase 1/2 Terminated
24 enrolled 12 charts
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Phase 2 Terminated
342 enrolled 14 charts
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Phase 1/2 Terminated
24 enrolled 18 charts
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
Phase 2 Terminated
12 enrolled 8 charts
CATChEz
Phase 2 Terminated
74 enrolled 13 charts
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
Phase 1/2 Terminated
3 enrolled 14 charts
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Phase NA Terminated
9 enrolled 8 charts
Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine
Phase NA Terminated
14 enrolled 11 charts
Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
Phase 2 Terminated
3 enrolled 7 charts
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
Phase 3 Terminated
3 enrolled 1 chart
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Phase 2 Terminated
4 enrolled 12 charts
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Phase 2 Terminated
9 enrolled 8 charts
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Phase 2 Terminated
10 enrolled 4 charts
Microwave Coagulation in Partial Nephrectomy Protocol
Phase NA Terminated
2 enrolled 8 charts
Interleukin-2 in Metastatic Kidney Cancer
Phase 2 Terminated
7 enrolled 4 charts
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
Vaccine Treatment of Kidney Cancer
Phase 2 Terminated
11 enrolled 12 charts
5-AZ
Phase 1/2 Terminated
11 enrolled 10 charts
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
Phase 2 Terminated
10 enrolled 14 charts
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Phase 2 Terminated
21 enrolled 8 charts
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
Phase 2 Terminated
1 enrolled 7 charts
Imaging Studies of Kidney Cancer Using 18F-VM4-037
Phase 2 Terminated
12 enrolled 20 charts
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Phase 2 Terminated
15 enrolled 9 charts
BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)
Phase 1/2 Terminated
10 enrolled 8 charts
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
Phase 2 Terminated
3 enrolled 8 charts
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
Phase 1/2 Terminated
9 enrolled 13 charts
Vandetanib to Treat Advanced Kidney Cancer
Phase 2 Terminated
3 enrolled 10 charts
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Phase 2 Terminated
17 enrolled 6 charts
Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Phase 2 Terminated
5 enrolled 10 charts
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Phase 1 Terminated
1 enrolled 2 charts
Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Phase 2 Terminated
12 enrolled 7 charts
Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2 Terminated
40 enrolled 2 charts